Free shipping on all orders over $ 500

 About 4 results found for searched term "Varenicline" (0.127 seconds)

Cat.No.  Name Target
M6268 Varenicline AChR/AChE
CP 526555
Varenicline (CP 526555) is a selective α4β2 nicotinic receptor partial agonist, it stimulates nicotine receptors more weakly than nicotine itself does.
M6273 Varenicline tartrate AChR/AChE
CP 526555-18
Varenicline Tartrate is a nicotinic AChR partial agonist, used to treat nicotine addiction.
M9058 Varenicline hydrochloride AChR/AChE
CP 526555 hcl; Chantix; Champix
Varenicline hydrochloride is a potent partial agonist of α4β2 nicotinic acetylcholine receptor (nAChR) and α3β4 nAChR, with EC50s of 2.3 μM and 55 μM, respectively. In addition, Varenicline hydrochloride is also a potent full agonist of α7 nAChRs. In addition, Varenicline hydrochloride is a potent full α7 nAChRs agonist with an EC50 of 18 μM.
M20984 Varenicline dihydrochloride AChR/AChE
Chantix, Champix
Varenicline (CP 526555, Chantix, Champix) dihydrochloride is a potent, partial agonist of α4β2 nicotinic acetylcholine receptor (nAChR) and α3β4 nAChR with EC50 of 2.3 μM and 55 μM, respectively. Varenicline dihydrochloride is a potent, full agonist of α7 nAChRs with EC50 of 18 μM. Varenicline is a prescription medication used for smoking cessation.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.